Rare diseases
Investigational molecules
Locations
Back to Slovakia14 clinical trials in Zvolen, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
SlovakiaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
SlovakiaEfficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial
SlovakiaEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
SlovakiaStudy on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis
SlovakiaEfficacy and safety of efgartigimod alfa in adults with Sjögren’s disease‑associated sensorimotor or sensory polyneuropathy: a phase 2 randomized placebo‑controlled study
SlovakiaPhase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus
SlovakiaStudy on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome
SlovakiaStudy of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before
SlovakiaBaricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
SlovakiaStudy on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome
SlovakiaStudy on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on Sjögren's Syndrome and Rheumatoid Arthritis, evaluating novel therapeutic approaches including efgartigimod and ianalumab for managing autoimmune manifestations.
Studies aim to improve quality of life for patients with chronic autoimmune conditions through innovative treatment strategies.
Clinical investigations examining Psoriatic Arthritis and Axial Spondyloarthritis, testing new biological treatments including sonelokimab and upadacitinib for inflammatory joint conditions.
Research focuses on developing targeted therapies for patients with chronic inflammatory joint diseases.
Innovative research in Acute Coronary Syndrome, evaluating milvexian's effectiveness in preventing recurrent cardiovascular events in post-heart attack patients.
Studies aim to reduce the risk of major adverse cardiovascular events through novel therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
